Please login to the form below

Not currently logged in
Email:
Password:

Nasdaq

This page shows the latest Nasdaq news and features for those working in and with pharma, biotech and healthcare.

AZ sells stake in Moderna for around $1.2bn

AZ sells stake in Moderna for around $1.2bn

The Massachusetts, US-based company was first listed on Nasdaq in 2018 at $23 per share, surging in value in 2020 after it started developing its two-dose COVID-19 vaccine.

Latest news

More from news
Approximately 4 fully matching, plus 72 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Syneos Health® Syneos Health®

    Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...